MAPK3 and ovarian carcinoma: In deed, malignant ascites is known to protect human ovarian cancer cells from TRAIL-induced apoptosis through αvβ5 integrin-mediated focal adhesion kinase/Akt activation and ERK1/2-Elk-1 signaling [17, 18].